Exact Mass: 511.2543
Exact Mass Matches: 511.2543
Found 500 metabolites which its exact mass value is equals to given mass value 511.2543
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
AFN911
AFN911 is a cytochrome P450 (CYP2D6) metabolite of Imatinib. Imatinib is a tyrosine kinase inhibitor, which is used to treat chronic myelogenous leukemia (CML) with BCR-ABL activity, gastrointestinal stromal tumors and acute lymphocytic leukemia (ALL). AFN911 is a 2-phenyl amino pyrimidine derivative. AFN911 is only found in individuals who have consumed or received the drug Imatinib.
CGP72383
CGP72383 is a metabolite of Imatinib. Cgp72383 belongs to the family of Acyclic Alkanes. These are acyclic hydrocarbons consisting only of n carbon atoms and m hydrogen atoms where m=2*n + 2.
Cerebrocrast
Bis(2-propoxyethyl) 4-[2-(difluoromethoxy)phenyl]-2,6-dimethyl-3,4-dihydropyridine-3,5-dicarboxylate
Ile His Asn Glu
Gln His Val Glu
His Ala Arg Glu
Ile Asn His Glu
Ala Glu His Arg
Ala Glu Arg His
Ala Phe Phe Gln
Ala Phe Gln Phe
Ala His Glu Arg
Ala His Arg Glu
Ala His Val Trp
Ala His Trp Val
Ala Lys Met Tyr
Ala Lys Tyr Met
Ala Met Lys Tyr
Ala Met Tyr Lys
Ala Gln Phe Phe
Ala Arg Glu His
Ala Arg His Glu
Ala Val His Trp
Ala Val Trp His
Ala Trp His Val
Ala Trp Val His
Ala Tyr Lys Met
Ala Tyr Met Lys
Cys Lys Val Tyr
Cys Lys Tyr Val
Cys Val Lys Tyr
Cys Val Tyr Lys
Cys Tyr Lys Val
Cys Tyr Val Lys
Asp His Ile Gln
Asp His Lys Leu
Asp His Leu Lys
Asp His Leu Gln
Asp His Gln Ile
Asp His Gln Leu
Asp Ile His Lys
Asp Ile His Gln
Asp Ile Lys His
Asp Ile Gln His
Asp Lys His Ile
Asp Lys His Leu
Asp Lys Ile His
Asp Lys Leu His
Asp Leu His Lys
Asp Leu His Gln
Asp Leu Lys His
Asp Leu Gln His
Asp Gln His Ile
Asp Gln His Leu
Asp Gln Ile His
Asp Gln Leu His
Glu Ala His Arg
Glu Ala Arg His
Glu His Ala Arg
Glu His Ile Asn
Glu His Lys Val
Glu His Leu Asn
Glu His Asn Ile
Glu His Asn Leu
Glu His Gln Val
Glu His Arg Ala
Glu His Val Lys
Glu His Val Gln
Glu Ile His Asn
Glu Ile Asn His
Glu Lys His Val
Glu Lys Val His
Glu Leu His Asn
Glu Leu Asn His
Glu Asn His Ile
Glu Asn His Leu
Glu Asn Ile His
Glu Asn Leu His
Glu Gln His Val
Glu Gln Val His
Glu Arg Ala His
Glu Arg His Ala
Glu Val His Lys
Glu Val His Gln
Glu Val Lys His
Glu Val Gln His
Phe Ala Phe Gln
Phe Ala Gln Phe
Phe Phe Ala Gln
Phe Phe Gln Ala
Phe Lys Met Ser
Phe Lys Ser Met
Phe Met Lys Ser
Phe Met Ser Lys
Phe Gln Ala Phe
Phe Gln Phe Ala
Phe Ser Lys Met
Phe Ser Met Lys
Gly His Ile Trp
Gly His Leu Trp
Gly His Trp Ile
Gly His Trp Leu
Gly Ile His Trp
Gly Ile Trp His
Gly Leu His Trp
Gly Leu Trp His
Gly Trp His Ile
Gly Trp His Leu
Gly Trp Ile His
Gly Trp Leu His
His Ala Glu Arg
His Ala Val Trp
His Ala Trp Val
His Asp Ile Lys
His Asp Ile Gln
His Asp Lys Ile
His Asp Lys Leu
His Asp Leu Lys
His Asp Leu Gln
His Asp Gln Ile
His Asp Gln Leu
His Glu Ala Arg
His Glu Ile Asn
His Glu Lys Val
His Glu Leu Asn
His Glu Asn Ile
His Glu Asn Leu
His Glu Gln Val
His Glu Arg Ala
His Glu Val Lys
His Glu Val Gln
His Gly Ile Trp
His Gly Leu Trp
His Gly Trp Ile
His Gly Trp Leu
His Ile Asp Lys
His Ile Asp Gln
His Ile Glu Asn
His Ile Gly Trp
His Ile Lys Asp
His Ile Asn Glu
His Ile Gln Asp
His Ile Trp Gly
His Lys Asp Ile
His Lys Asp Leu
His Lys Glu Val
His Lys Leu Asp
His Lys Met Pro
His Lys Asn Asn
His Lys Pro Met
His Lys Val Glu
His Leu Asp Lys
His Leu Asp Gln
His Leu Glu Asn
His Leu Gly Trp
His Leu Asn Glu
His Leu Gln Asp
His Leu Trp Gly
His Met Lys Pro
His Met Pro Lys
His Asn Glu Ile
His Asn Glu Leu
His Asn Ile Glu
His Asn Lys Asn
His Asn Leu Glu
His Asn Asn Lys
His Pro Lys Met
His Pro Met Lys
His Gln Asp Ile
His Gln Asp Leu
His Gln Glu Val
His Gln Ile Asp
His Gln Leu Asp
His Gln Val Glu
His Arg Ala Glu
His Arg Glu Ala
His Val Ala Trp
His Val Glu Lys
His Val Glu Gln
His Val Lys Glu
His Val Gln Glu
His Val Trp Ala
His Trp Ala Val
His Trp Gly Ile
His Trp Gly Leu
His Trp Ile Gly
His Trp Leu Gly
His Trp Val Ala
Ile Asp His Lys
Ile Asp His Gln
Ile Asp Lys His
Ile Asp Gln His
Ile Glu His Asn
Ile Glu Asn His
Ile Gly His Trp
Ile Gly Trp His
Ile His Asp Lys
Ile His Asp Gln
Ile His Glu Asn
Ile His Gly Trp
Ile His Lys Asp
Ile His Gln Asp
Ile His Trp Gly
Ile Lys Asp His
Ile Lys His Asp
Ile Asn Glu His
Ile Gln Asp His
Ile Gln His Asp
Ile Trp Gly His
Ile Trp His Gly
Lys Ala Met Tyr
Lys Ala Tyr Met
Lys Cys Val Tyr
Lys Cys Tyr Val
Lys Asp His Ile
Lys Asp His Leu
Lys Asp Ile His
Lys Asp Leu His
Lys Glu His Val
Lys Glu Val His
Lys Phe Met Ser
Lys Phe Ser Met
Lys His Asp Ile
Lys His Asp Leu
Lys His Met Pro
Lys His Asn Asn
Lys His Pro Met
Lys Met Ala Tyr
Lys Met Phe Ser
Lys Met His Pro
Lys Met Pro His
Lys Met Ser Phe
Lys Met Tyr Ala
Lys Asn His Asn
Lys Asn Asn His
Lys Pro His Met
Lys Pro Met His
Lys Ser Phe Met
Lys Ser Met Phe
Lys Thr Thr Tyr
Lys Thr Tyr Thr
Lys Val Cys Tyr
Lys Val Glu His
Lys Val Tyr Cys
Lys Tyr Ala Met
Lys Tyr Cys Val
Lys Tyr Met Ala
Lys Tyr Thr Thr
Lys Tyr Val Cys
Leu Asp His Gln
Leu Asp Gln His
Leu Glu His Asn
Leu Glu Asn His
Leu Gly His Trp
Leu Gly Trp His
Leu His Asp Gln
Leu His Glu Asn
Leu His Gly Trp
Leu His Asn Glu
Leu His Gln Asp
Leu His Trp Gly
Leu Asn Glu His
Leu Asn His Glu
Leu Gln Asp His
Leu Gln His Asp
Leu Trp Gly His
Leu Trp His Gly
Met Ala Lys Tyr
Met Ala Tyr Lys
Met Phe Lys Ser
Met Phe Ser Lys
Met His Lys Pro
Met His Pro Lys
Met Lys Ala Tyr
Met Lys Phe Ser
Met Lys His Pro
Met Lys Pro His
Met Lys Ser Phe
Met Lys Tyr Ala
Met Pro His Lys
Met Pro Lys His
Met Ser Phe Lys
Met Ser Lys Phe
Met Tyr Ala Lys
Met Tyr Lys Ala
Asn Glu His Ile
Asn Glu His Leu
Asn Glu Ile His
Asn Glu Leu His
Asn His Glu Ile
Asn His Glu Leu
Asn His Ile Glu
Asn His Lys Asn
Asn His Leu Glu
Asn His Asn Lys
Asn Ile Glu His
Asn Ile His Glu
Asn Lys His Asn
Asn Lys Asn His
Asn Leu Glu His
Asn Leu His Glu
Asn Asn His Lys
Asn Asn Lys His
Pro His Lys Met
Pro His Met Lys
Pro Lys His Met
Pro Lys Met His
Pro Met His Lys
Pro Met Lys His
Gln Ala Phe Phe
Gln Asp His Ile
Gln Asp His Leu
Gln Asp Ile His
Gln Asp Leu His
Gln Glu His Val
Gln Glu Val His
Gln Phe Ala Phe
Gln Phe Phe Ala
Gln His Asp Ile
Gln His Asp Leu
Gln His Glu Val
Gln His Ile Asp
Gln His Leu Asp
Gln Ile Asp His
Gln Ile His Asp
Gln Leu Asp His
Gln Leu His Asp
Gln Val Glu His
Gln Val His Glu
Arg Ala Glu His
Arg Ala His Glu
Arg Glu Ala His
Arg Glu His Ala
Arg His Ala Glu
Arg His Glu Ala
Arg Ser Ser Tyr
Arg Ser Tyr Ser
Arg Tyr Ser Ser
Ser Phe Lys Met
Ser Phe Met Lys
Ser Lys Phe Met
Ser Lys Met Phe
Ser Met Phe Lys
Ser Met Lys Phe
Ser Arg Ser Tyr
Ser Arg Tyr Ser
Ser Ser Arg Tyr
Ser Ser Tyr Arg
Ser Tyr Arg Ser
Ser Tyr Ser Arg
Thr Lys Thr Tyr
Thr Lys Tyr Thr
Thr Thr Lys Tyr
Thr Thr Tyr Lys
Thr Tyr Lys Thr
Thr Tyr Thr Lys
Val Ala His Trp
Val Ala Trp His
Val Cys Lys Tyr
Val Cys Tyr Lys
Val Glu His Gln
Val Glu Gln His
Val His Ala Trp
Val His Glu Gln
Val His Gln Glu
Val His Trp Ala
Val Lys Cys Tyr
Val Lys Tyr Cys
Val Gln Glu His
Val Gln His Glu
Val Trp Ala His
Val Trp His Ala
Val Tyr Cys Lys
Val Tyr Lys Cys
Trp Ala His Val
Trp Ala Val His
Trp Gly His Ile
Trp Gly His Leu
Trp Gly Ile His
Trp Gly Leu His
Trp His Ala Val
Trp His Gly Ile
Trp His Gly Leu
Trp His Ile Gly
Trp His Leu Gly
Trp His Val Ala
Trp Ile Gly His
Trp Ile His Gly
Trp Leu Gly His
Trp Leu His Gly
Trp Val Ala His
Trp Val His Ala
Tyr Ala Lys Met
Tyr Ala Met Lys
Tyr Cys Lys Val
Tyr Cys Val Lys
Tyr Lys Ala Met
Tyr Lys Cys Val
Tyr Lys Met Ala
Tyr Lys Thr Thr
Tyr Lys Val Cys
Tyr Met Ala Lys
Tyr Met Lys Ala
Tyr Arg Ser Ser
Tyr Ser Arg Ser
Tyr Ser Ser Arg
Tyr Thr Lys Thr
Tyr Thr Thr Lys
Tyr Val Cys Lys
Tyr Val Lys Cys
AFN911
Hydrocortamate Hydrochloride
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid
(1S)-2-oxobornane-10-sulphonic acid, compound with 7-[2-(diethylamino)ethyl]-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione (1:1)
1,1-(Isopropylimino)bis{3-[4-(2-methoxyethyl)phenoxy]-2-propanol} hydrochloride (1:1)
1,3,5-Triazine, 2,4-diphenyl-6-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)[1,1-biphenyl]-3-yl]-
BUTANE
CGP72383 is a metabolite of Imatinib. Cgp72383 belongs to the family of Acyclic Alkanes. These are acyclic hydrocarbons consisting only of n carbon atoms and m hydrogen atoms where m=2*n + 2. Aerosol propellant
[(2R,3S,4S,5R,6S)-4-amino-6-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2S,3R,5S,6R)-3-amino-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-3,5-dihydroxyoxan-2-yl]methyl carbamate
6-[(2R,5R)-3-hydroxy-5-[4-[[(2R)-2-hydroxy-2-(4-hydroxyphenyl)ethyl]amino]-4-oxobutanoyl]oxy-6-methyloxan-2-yl]oxyheptanoic acid
N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-5-(oxane-4-carbonyl)-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-5-[4-oxanyl(oxo)methyl]-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-5-(oxane-4-carbonyl)-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-5-(oxane-4-carbonyl)-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-5-(oxane-4-carbonyl)-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-5-[4-oxanyl(oxo)methyl]-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-5-[4-oxanyl(oxo)methyl]-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
(2R)-2-[(4R,5R)-5-[[cyclopentylmethyl(methyl)amino]methyl]-4-methyl-1,1-dioxo-8-[2-(3-pyridinyl)ethynyl]-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
N-[(4R,7R,8R)-5-[(2-fluorophenyl)-oxomethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
N-[(4S,7S,8R)-5-[(2-fluorophenyl)-oxomethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
N-[(4R,7R,8S)-5-[(2-fluorophenyl)-oxomethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
N-[(4R,7S,8R)-5-[(2-fluorophenyl)-oxomethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
N-[(4S,7R,8S)-5-[(2-fluorophenyl)-oxomethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1,3-benzodioxole-5-carboxamide
(2S)-2-[(4R,5R)-5-[[cyclopentylmethyl(methyl)amino]methyl]-4-methyl-1,1-dioxo-8-[2-(3-pyridinyl)ethynyl]-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-5-[4-oxanyl(oxo)methyl]-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
N-[(4R,7S,8S)-5-[(2-fluorophenyl)-oxomethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
N-[(4S,7R,8R)-5-[(2-fluorophenyl)-oxomethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
N-[(4S,7S,8S)-5-[(2-fluorophenyl)-oxomethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
4-methoxy-N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(1-oxopropyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
(3R)-2-[(R)-tert-butylsulfinyl]-4-[3-(1-cyclopentenyl)phenyl]-3-(2-hydroxyethyl)-N-(2-methoxyethyl)-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide
(3S)-2-[(S)-tert-butylsulfinyl]-4-[3-(1-cyclopentenyl)phenyl]-3-(2-hydroxyethyl)-N-(2-methoxyethyl)-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide
eurysterol B(1-)
An organosulfonate oxoanion obtained by the deprotonation of the sulfate group of eurysterol B hydrogen sulfate.
11beta,17-dihydroxy-3,20-dioxopregn-4-en-21-yl N,N-diethylglycinate hydrochloride
2-Amino-3-[2,3-di(octanoyloxy)propoxy-hydroxyphosphoryl]oxypropanoic acid
2-Amino-3-[(3-heptanoyloxy-2-nonanoyloxypropoxy)-hydroxyphosphoryl]oxypropanoic acid
2-Amino-3-[(3-butanoyloxy-2-dodecanoyloxypropoxy)-hydroxyphosphoryl]oxypropanoic acid
2-Amino-3-[(2-decanoyloxy-3-hexanoyloxypropoxy)-hydroxyphosphoryl]oxypropanoic acid
2-Amino-3-[hydroxy-(3-propanoyloxy-2-tridecanoyloxypropoxy)phosphoryl]oxypropanoic acid
2-Amino-3-[hydroxy-(3-pentanoyloxy-2-undecanoyloxypropoxy)phosphoryl]oxypropanoic acid
3-[(3-Acetyloxy-2-tetradecanoyloxypropoxy)-hydroxyphosphoryl]oxy-2-aminopropanoic acid
1,2-dioctanoyl-sn-glycero-3-phosphoserine
A 3-sn-phosphatidyl-L-serine in which the two phosphatidyl acyl groups are specified as octanoyl.
Sulfoglycolithocholate(2-)
A steroid sulfate oxoanion and N-acylglycinate that is the dianion of sulfoglycolithocholic acid arising from deprotonation of carboxylic acid and sulfate functions; major species at pH 7.3.
Upidosin
Upidosin (Rec 15/2739) is an α-1 adrenoceptor (α-1 AR) antagonist. Upidosin shows moderate selectivity for the α-1A AR subtype. Upidosin shows uroselectivity in urethra and prostate with a Kb value of 2-3 nM higher than in ear artery and aorta with a Kb value of 20-100 nM. Upidosin inhibits [3H]prazosin binding to cloned human α-1A adrenergic receptor. Upidosin can be used for the research of urethral obstruction[1].